Skip to Main Content

Paper Details

HLA Heterozygote Advantage against HIV-1 Is Driven by Quantitative and Qualitative Differences in HLA Allele-Specific Peptide Presentation.
Mol Biol Evol
44
2020
HIV, HIV-1, HLA, HLA Allele, HLA alleles, HLA class I alleles, HLA heterozygotes, HLA variants, HLA-B, HLA-B*57:01 variant, human, human leukocyte antigen, humans, immune cells
Author NameAffiliation
Paul J McLarenJC Wilt Infectious Diseases Research Center
Paul J McLarenUniversity of Manitoba
Mary CarringtonFrederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University
Mary CarringtonFrederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University
Jacques FellayGlobal Health Institute, Ecole Polytechnique Federale de Lausanne
Jacques Fellay
Jacques FellayLausanne University Hospital and University of Lausanne
  • 1 - 9

Datasets

Release 1.2